Part 6: Omega 6 & 3: Science vs. Marketing

Omega 6 & 3: Evidence-Based Benefits

This is the final article in our six-part series on essential fatty acids. We've covered the basics, explored where omega-6 and omega-3 come from, examined what they do, and established why they matter for long-term health. We've moved from foundational science to dispelling myths. In this concluding piece, we trace how the discovery of essential fats became distorted by marketing—and what the evidence actually shows.

Section 1: Science vs Marketing

Millions have been led to believe by the internet that seed oils are toxic and omega-6 fatty acids trigger chronic inflammation. At the same time, supplement companies promote the idea that omega-3s are essential miracle nutrients, best consumed directly as DHA and EPA. Both narratives arise from a similar distortion of scientific facts.

Here's what happened: decades of research focused on omega-3 deficiency in Western diets. That research was solid. The marketing interpretation was not. Omega-3 became "good," omega-6 became "bad," and the ratio between them became an obsession—despite weak evidence that ratios matter more than absolute amounts.

The truth is simpler and less dramatic: both omega-6 (linoleic acid) and omega-3 (alpha-linolenic acid) are essential fatty acids. Your body cannot make them. You must eat them. The 2010 FAO/WHO expert consultation on fats and fatty acids established evidence-based recommendations: adults need approximately 1 tablespoon of polyunsaturated fatty acids daily for long-term health.

A pregnant woman in her second trimester converts ALA to DHA far more efficiently than a sedentary adult. An infant's brain has different essential fatty acid requirements than an adolescent's. A lactating mother synthesizes long-chain omega-3s differently from her teenage son. Yet the marketing remains the same for everyone: fear seed oils, buy supplements, obsess over ratios.

Hemp hearts and hempseed oil provide both essential fatty acids from whole food sources—80% polyunsaturated fat including both omega-6 and omega-3. Not isolated oils. Not synthetic supplements. The question is not whether one fatty acid is "better" than another. It's whether you're providing your body with adequate amounts of both.

That is what this article explores: how legitimate science about essential fatty acids became distorted by marketing, and what the evidence actually shows.

Section 2: How Science Became Marketing

The Discovery (1929-1931)

In 1929, George and Mildred Burr made a discovery that would reshape nutritional science: certain fats were essential for life (Burr & Burr, 1929). Rats deprived of specific fatty acids failed to grow, developed skin lesions, and eventually died—even when given adequate calories and all known vitamins. By 1931, the Burrs had identified the essential factor: linoleic acid, an omega-6 fatty acid. Later research showed that linolenic acid (omega-3) or arachidonic acid could serve similar functions. 

George O Burr

This was revolutionary. Before the Burrs, fats were considered mere fuel—a concentrated source of calories. The idea that specific fatty acid structures were biologically necessary forced scientists to rethink the role of dietary fats entirely. Both omega-6 and omega-3 fatty acids were essential. Neither was optional. Neither was superior.

Ironically, linolenic acid had first been described in scientific literature in 1887. The source? Hempseed oil.

The same year the Burrs published their discovery, gynecologists working with artificial insemination made another observation: extracts of seminal fluid caused uterine tissue to contract. This led to the discovery of prostaglandins—powerful cell messengers that would later become central to the omega-3 marketing narrative.

The Industrial Era (1950s-1970s)

By 1950, scientists understood the metabolic pathways. Ralph Holman discovered that linoleic acid (omega-6) was the precursor to arachidonic acid, and that alpha-linolenic acid (omega-3) was the precursor to DHA and EPA. The biochemistry was clear: humans needed both parent fatty acids, and the body could elongate and desaturate them into longer-chain derivatives.

But industrial food processing was about to make omega-3 fatty acids inconvenient.

In 1951, Herbert Dutton proved that linolenic acid caused off-flavors and odors in soybean oil (Dutton, 1951). This was a problem. Soybean oil was cheap, abundant, and increasingly central to American food production. The solution? Partial hydrogenation—a process that selectively removed the troublesome omega-3s while leaving the more stable omega-6s intact. The food supply shifted dramatically: omega-6 fatty acids increased, omega-3s decreased.

In 1962, Ralph Holman's mother became one of the first documented cases of essential fatty acid deficiency in humans. She died from a deficiency of linoleic acid—omega-6. The medical establishment recognized that both omega-6 and omega-3 fatty acids were essential for human health. But the food supply was already diverging from this biological reality.

The Greenland Hypothesis (1972-1973)

In 1970, a young Danish physician named Jørn Dyerberg traveled to Greenland with his supervisor, Hans Bang. They'd read an editorial reporting that Greenland health records showed lower rates of cardiac death among the Inuit population. Intrigued, they convinced Inuit subjects to provide blood samples. 

Bang & Dyerberg with Greenland Inuit

Bang and Dyerberg's 1972 report was careful: compared with Danes, Greenland Inuits had lower serum cholesterol and triglycerides despite a diet rich in fat and blubber. Their blood work showed two sharp peaks—EPA and DHA, omega-3 fatty acids abundant in fish, seals, and whales. The researchers suggested that omega-3-rich blood might reduce heart attacks and strokes (Bang & Dyerberg, 1972).

This was solid observational science. Association studies are useful in identifying phenomena worth investigating. They don't establish causation, but they can point researchers toward important questions.

One year later, in 1973, William Lands published findings that would become even more significant: prostaglandins made from omega-3 fatty acids were much less inflammatory than those made from omega-6 fatty acids. This discovery had immediate clinical applications. Fish oil began to be used therapeutically for arthritis, ulcerative colitis, Crohn's disease, and other inflammatory conditions (Allport, 2006).

The science was real. The applications were legitimate. But the interpretation was about to be distorted.

The Supplement Industry Emerges (1980s-1990s)

By the 1980s, several threads converged. The food supply was demonstrably different from what humans had evolved eating—higher in omega-6s, lower in omega-3s. Association studies like Dyerberg's Greenland work suggested that populations eating more omega-3s had better cardiovascular outcomes. And Lands' prostaglandin research showed a plausible anti-inflammatory mechanism.

When provocative possibility collided with powerful marketing—Viking traders, Eskimo seal hunters, and the mystique of marine omega-3s—market forces took over.

The fish oil business evolved from a home remedy into a massive medical enterprise. When large-scale whale-oil refining ended, Norwegians pivoted to monetize their marine resources. The omega-3 supplement industry was born.

Then came the critical regulatory moment. In 1976, Linus Pauling's recommendation of 3,000 milligrams of vitamin C daily prompted the FDA to consider limiting megavitamin dosages. The supplement industry saw this as an existential threat. In response, they pushed through the 1994 Dietary Supplement Health and Education Act (Dietary Supplement Health and Education Act, 1994).

This legislation created what one historian called "a third hermaphroditic category" that was neither food nor drug. Supplement makers could now put whatever they wanted in a capsule and sell it as a supplement. No science or evidence of efficacy was necessary.

The door was wide open.

The Ratio Obsession (2000s-2010s)

With regulatory constraints removed, omega-3 marketing escalated. Sales of omega-3 supplements reached more than $15 billion annually by the 2010s (Greenberg, 2018).

The message simplified and hardened: omega-3s were unambiguously good. Omega-6s were increasingly portrayed as bad. And the ratio between them became an obsession.

Marketing specialists surveyed consumers and discovered a narrative goldmine: people could be convinced they were on a "life-health journey." The marketing pitch was powerful and emotional: omega-3s would help you live longer, think clearer, stay healthier.

Meanwhile, omega-6 fatty acids—which had been recognized as essential since the Burrs' work in 1929—were rebranded as inflammatory villains. Seed oils became toxic. Ratios became gospel. The science showing that absolute amounts mattered more than ratios was ignored.

The Evidence Evolves (2012-Present)

In 2012, the Journal of the American Medical Association published the Rizos meta-analysis examining omega-3 supplementation for primary prevention of stroke. The conclusion challenged decades of marketing: omega-3 supplementation was not associated with reduced stroke risk in people without existing cardiovascular disease (Rizos et al., 2012).

The supplement industry doubled down. Marketing pivoted from cardiovascular claims to inflammation, brain health, and cognitive function.

By 2017, the American Heart Association reviewed the evidence and issued clear recommendations: omega-3 supplements were "not indicated" for primary prevention of coronary heart disease in the general population, prevention of cardiovascular mortality in diabetes, prevention of CHD among high-risk patients, primary prevention of stroke, or prevention of atrial fibrillation. The supplements showed benefit only for secondary prevention—people who already had coronary heart disease or heart failure.

In other words, omega-3 supplements weren't preventing cardiovascular disease in healthy people. They might help manage existing disease, but they were not the preventive miracle the marketing claimed.

Meanwhile, research on dietary omega-3 fatty acids continued. A 2025 study examining omega-3 intake in patients with cardiovascular disease found something notable: total omega-3 fatty acids from food were inversely associated with both all-cause mortality and cardiovascular mortality. But when researchers analyzed individual omega-3 fatty acids, only ALA (alpha-linolenic acid—the plant-based omega-3) showed this inverse association. EPA, DPA, and DHA showed no significant association (Yan et al., 2025).

The optimal intake? Approximately 2 grams of ALA daily.

This is the omega-3 found in hempseed oil, hemp hearts, flaxseed, and walnuts - not the EPA and DHA that the supplement industry has been marketing for decades.

Section 3: What the Evidence Actually Shows

The omega-3 supplement industry is a $15 billion (2010 figure) global enterprise, built largely on association studies and carefully cultivated narratives. But the evolving science tells a more specific story than the marketing suggests.

Both linoleic acid (omega-6) and alpha-linolenic acid (omega-3) are essential fatty acids. Your body cannot synthesize them. You must obtain them from food. The 2010 FAO/WHO expert consultation on fats and fatty acids established evidence-based recommendations for long-term health: adults need approximately one tablespoon of polyunsaturated fatty acids daily (FAO Fatty Acid Report, 2008).

Not one fatty acid. Not a specific ratio. Both essential fatty acids, in adequate amounts.

The ratio obsession that dominates supplement marketing and seed oil panic has weak scientific support. Research consistently shows that absolute amounts of omega-6 and omega-3 fatty acids matter more than their ratio. A 2006 study in the American Journal of Clinical Nutrition found that ALA conversion to EPA and DHA is influenced by the absolute amounts of ALA and linoleic acid in the diet—not by their ratio (Petra LL Goyens et al., 2006).

The inflammatory narrative is similarly oversimplified. Yes, omega-6 fatty acids can be converted to arachidonic acid, which produces prostaglandins involved in inflammatory responses. But inflammation is not inherently bad—it is a necessary immune function. And the same omega-6 pathway also produces anti-inflammatory compounds. The body maintains balance.

Section 4: The Whole Food Solution

When you strip away the marketing narratives and ratio obsessions, you are left with a simpler truth: humans need both essential fatty acids from food sources.

Hempseed oil delivers this efficiently. One tablespoon provides approximately 14 grams of polyunsaturated fatty acids—both omega-6 and omega-3—meeting the FAO daily recommendation in a single serving.

Hemp hearts provide the same essential fatty acids in a whole food form that also includes complete protein, substantial fiber, bioavailable minerals, and protective vitamin E. Three tablespoons (40g) provide approximately 14 grams of polyunsaturated fatty acids. This matters because whole food sources behave differently than isolated supplements.

When you consume hemp hearts, you're getting essential fatty acids in a matrix that includes other nutrients influencing absorption, metabolism, and utilization. The protein slows digestion. The fiber moderates blood sugar response. The minerals support enzymatic processes. The vitamin E protects the polyunsaturated fats from oxidation. The beauty of this approach is its simplicity. No need to calculate ratios. No need to fear seed oils while megadosing fish oil capsules. No need to navigate the supplement industry's shifting health claims as cardiovascular promises give way to inflammation narratives then to brain health marketing.

Just evidence-based nutrition from whole food sources that provide both essential fatty acids.

Section 5: Conclusion

We've traced the story of essential fatty acids from the Burrs' 1929 discovery, through the industrial processing era that stripped omega-3s from the food supply, to the supplement industry's carefully constructed narrative that omega-3s are miracle nutrients and omega-6s are inflammatory toxins.

The truth is both simpler and more nuanced: both omega-6 and omega-3 fatty acids are essential. You must eat them. And the evidence shows that absolute amounts matter more than ratios, that whole food sources behave differently from isolated supplements, and that for the general population seeking cardiovascular health, dietary ALA provides benefits that omega-3 supplements marketed for primary prevention have failed to demonstrate.

Hempseed oil and hemp hearts provide both essential fatty acids in whole food forms—80% polyunsaturated fat including both omega-6 and omega-3. One tablespoon of hempseed oil or three tablespoons of hemp hearts meets the FAO daily recommendation for polyunsaturated fatty acid intake, including the approximately 2 grams of ALA associated with cardiovascular benefits.

No marketing hype. No ratio obsessions. No fear-mongering about seed oils or expensive supplement regimens for healthy people seeking disease prevention.

Just evidence-based nutrition from foods that have been providing essential fatty acids since linolenic acid was first identified in hempseed oil in 1887—decades before anyone knew why it mattered.

The supplement industry will continue selling omega-3 capsules. Influencers will continue warning about seed oils. Marketing narratives will continue evolving to match whatever health concern is trending. But the science remains clear: you need both essential fatty acids, in adequate amounts, from quality sources.

Hempseed oil and hemp hearts offer a practical way to do that as part of everyday eating.

Choose evidence over fear. Choose whole foods over isolated supplements. Choose what human biology actually requires over what the supplement industry wants to sell you. Explore our hempseed oil and hemp hearts if you want a simple, food-first way to support your intake of essential fatty acids.

Your body will know the difference.

References

Allport, S. (2006). The Queen of Fats. Why omega-3s were removed from the western diet and what we can do to replace them. Los Angeles: University of California Press.

Bang, H., & Dyerberg, J. (1972). Plasma Lipids and Lipoproteins in Greenlandic West Coast Eskimos. Acta Medica Scandinavica, 85-94.

Burr, G., & Burr, M. (1929). A NEW DEFICIENCY DISEASE PRODUCED BY THE RIGID EXCLUSION OF FAT FROM THE DIET. American Society for Biochemistry and Molecular Biology.

Dietary Supplement Health and Education Act . (1994, October). Retrieved from National Institutes of Health

Dutton, H. .. (1951). The flavor problem of soybean oil. VIII. Linolenic acid. J Am Oil Chem Soc, 115-118.

FAO Fatty Acid Report. (2008, November 10-14). Nutrition: Food and Agricultural Organisation. Retrieved from Food and Agricultural Organisation of the United Nations

Greenberg, P. (2018). The Omega Principle. New York: Penguin Press.

Petra LL Goyens, M. E. (2006). Conversion of ALA in humans is influenced by the absolute amounts of ALA and LA in the diet and not by their ratio. American Journal Clinical Nutrition, 44-53.

Rizos, E. C. (2012). Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA, 1024-1033.

Yan, Y. L. (2025). Association of dietary omega-3 fatty acids intake with all-cause and cardiovascular disease-specific mortality among individuals with cardiovascular disease. Scientific Reports.